124 related articles for article (PubMed ID: 19161362)
1. Ability of low-molecular-weight heparin to alleviate proteinuria by inhibiting respiratory syncytial virus infection.
Guo Y; Wang Z; Dong L; Wu J; Zhai S; Liu D
Nephrology (Carlton); 2008 Oct; 13(7):545-53. PubMed ID: 19161362
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus nephropathy in rats.
Liu XM; Wang Z; Guo Y
Kidney Int; 2007 Mar; 71(5):388-96. PubMed ID: 17200682
[TBL] [Abstract][Full Text] [Related]
3. HS N-sulfation and iduronic acids play an important role in the infection of respiratory syncytial virus in vitro.
Dong LQ; Wang XQ; Guo YN; Wu J; Li S; Yu P; Wang Z
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(14):1864-8. PubMed ID: 23877848
[TBL] [Abstract][Full Text] [Related]
4. Low molecular weight heparin may benefit nephrotic remission in steroid‑sensitive nephrotic syndrome via inhibiting elastase.
Zhai S; Hu L; Zhong L; Tao Y; Wang Z
Mol Med Rep; 2017 Dec; 16(6):8613-8618. PubMed ID: 28990100
[TBL] [Abstract][Full Text] [Related]
5. [Activation of TLR3 pathway in the pathogenesis of nephrotic syndrome induced by respiratory syncytial virus in rat model].
Wu J; Wang Z; Guo YN; Dong LQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):600-3, 625. PubMed ID: 20848777
[TBL] [Abstract][Full Text] [Related]
6. [The protective effect of low molecular weight heparin on early nephropathy in diabetic rats].
Guo H; Gan L; Yu Z
Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(21):1327-9. PubMed ID: 16200729
[TBL] [Abstract][Full Text] [Related]
7. [Expression of heparanase in kidney of rats with respiratory syncytial virus nephropathy and its relationship with proteinurina].
Tao YH; Wang Z; Zhou YR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 45(2):212-5, 224. PubMed ID: 24749342
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
Dos Santos AM; de Olveira AV; da Silva Lemos CC; Mandarim-de-Lacerda CA; Bregman R
Pathol Res Pract; 2006; 202(3):157-63. PubMed ID: 16492522
[TBL] [Abstract][Full Text] [Related]
9. [Effect of heparin and low-molecular-weight heparin on proliferative glomerulonephritis].
Morita Y; Makino H; Ota K; Wada J; Shikata K; Kashihara N; Ikeda S; Ogura T; Ota Z
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):832-8. PubMed ID: 8072221
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study of low-molecular weight heparin on ameliorating progressive glomerulosclerosis].
Zhang H; Ji LZ; Wu K
Hunan Yi Ke Da Xue Xue Bao; 2001 Feb; 26(1):7-9. PubMed ID: 12536602
[TBL] [Abstract][Full Text] [Related]
11. Respiratory Syncytial Virus Aggravates Renal Injury through Cytokines and Direct Renal Injury.
Zhai S; Hu L; Zhong L; Guo Y; Dong L; Jia R; Wang Z
Front Cell Infect Microbiol; 2016; 6():112. PubMed ID: 27747195
[TBL] [Abstract][Full Text] [Related]
12. Diabetic rats treated by low molecular weight heparin OP 2123/parnaparin: morphological changes in the kidney and heart.
Artico M; De Santis S; Tranquilli Leali FM; Cavallotti D; Celestini A; Cavallotti C
J Diabetes Complications; 2004; 18(2):119-25. PubMed ID: 15120707
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of low-molecular-weight heparin reversal by platelet factor 4.
Fiore MM; Mackie IM
Thromb Res; 2009 May; 124(1):149-55. PubMed ID: 19195682
[TBL] [Abstract][Full Text] [Related]
14. Beneficial cardio-renovascular effects of a low-molecular-weight heparin-derivative on adriamycin-induced glycosaminoglycanuria and tissue lipid abnormalities.
Deepa PR; Varalakshmi P
Toxicology; 2005 Jul; 211(1-2):77-85. PubMed ID: 15863250
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.
Lee YK; Kim SK; Lee DY; Lee S; Kim CY; Shin HC; Moon HT; Byun Y
J Control Release; 2006 Apr; 111(3):290-8. PubMed ID: 16497407
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
17. Low molecular weight heparin suppresses tumor necrosis factor expression from deep vein thrombosis.
Carr JA; Cho JS
Ann Vasc Surg; 2007 Jan; 21(1):50-5. PubMed ID: 17349336
[TBL] [Abstract][Full Text] [Related]
18. Heparin-like structures on respiratory syncytial virus are involved in its infectivity in vitro.
Bourgeois C; Bour JB; Lidholt K; Gauthray C; Pothier P
J Virol; 1998 Sep; 72(9):7221-7. PubMed ID: 9696816
[TBL] [Abstract][Full Text] [Related]
19. DSCG reduces RSV-induced illness in RSV-infected mice.
Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
[TBL] [Abstract][Full Text] [Related]
20. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
Naz R; Naz S; Mehboob M; Khalid GH
J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
